Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Influenza
Biotech
GSK, Vir end flu drug alliance, removing key piece of $345M pact
The change frees Vir to “actively” pitch flu candidates to other companies while continuing to work with GSK on different respiratory pathogens.
Nick Paul Taylor
Feb 23, 2024 5:10am
Veru needs cash for fresh trial of respiratory distress drug
Feb 8, 2024 10:45am
GSK tips 12 blockbuster launches to soften HIV patent loss
Jan 31, 2024 7:45am
Would you eat a lollipop without candy? The flu virus won't
Jan 16, 2024 9:02am
Pfizer, BioNTech prep flu-COVID mRNA combo vaccine for phase 3
Oct 26, 2023 9:32am
Pneumagen's flu antiviral stands up to human challenge study
Oct 2, 2023 4:00am